HCAT Health Catalyst, Inc.
Nasdaq · SEC CIK 1636422 · EDGAR
- Bought, last 12 months
- $105.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $200.6K 2 sales by 2 insiders
- Filings on record
- 343 since 2021-07-06, latest 2026-09-16 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Larson-Green Julie | Dir | — | $128.2K |
| Kohl Simeon | CEO, Dir | $105.4K | — |
| Landry Benjamin | GC | — | $72.4K |
| Albert Benjamin | CEO, Dir | — | — |
| Hoggard Green Jill | Dir | — | — |
| Freeman Kevin Lee | Chief Commercial Off | — | — |
| Alger Jason | CFO | — | — |
| Burton Daniel D. | CEO, Dir | — | — |
| Gallagher Duncan | Dir | — | — |
| Llewelyn Linda | CHRO | — | — |
Transactions 414
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | 2023-06-06 | HCAT | Landry Benjamin | GC | S - Sale | $11.84 | -1,078 | 29.8K | -3% | -$12.8K | |
| 2023-06-08 | 2023-06-06 | HCAT | Alger Jason | CAO | S - Sale | $11.84 | -2,370 | 60.1K | -4% | -$28.1K | |
| 2023-06-05 | 2023-06-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $11.24 | -1,038 | 179.2K | -0.6% | -$11.7K | |
| 2023-06-05 | 2023-06-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $11.24 | -1,548 | 84.3K | -2% | -$17.4K | |
| 2023-06-05 | 2023-06-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $11.24 | -4,433 | 239.3K | -2% | -$49.8K | |
| 2023-06-05 | 2023-06-05 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $12.00 | -650 | 238.7K | -0.3% | -$7,800 | |
| 2023-06-05 | 2023-06-01 | HCAT | Landry Benjamin | GC | F - Tax | $11.24 | -577 | 30.9K | -2% | -$6,485 | |
| 2023-06-05 | 2023-06-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $11.24 | -7,411 | 912.0K | -0.8% | -$83.3K | |
| 2023-06-05 | 2023-06-01 | HCAT | Alger Jason | CAO | F - Tax | $11.24 | -1,066 | 62.4K | -2% | -$12.0K | |
| 2023-06-05 | 2023-06-01 | HCAT | Bickmore Anne Marie | COO, Chief Product Off | F - Tax | $11.24 | -1,755 | 69.5K | -2% | -$19.7K | |
| 2023-05-12 | 2023-05-12 | HCAT | Burton Daniel D. | CEO, Dir | P - Purchase | $10.19 | +49.0K | 919.4K | +6% | +$499.8K | |
| 2023-05-04 | 2023-05-03 | HCAT | Bickmore Anne Marie | COO, Chief Product Off | A - Grant | $0.00 | +35.0K | 71.3K | +96% | $0 | |
| 2023-05-04 | 2023-05-03 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +20.0K | 31.5K | +174% | $0 | |
| D | 2023-03-24 | 2023-03-22 | HCAT | Horstmeier Paul | COO | M - OptEx | $4.42 | +50.0K | 204.9K | +32% | +$221.0K |
| 2023-03-07 | 2023-03-03 | HCAT | Alger Jason | CAO | S - Sale | $14.23 | -2,967 | 55.3K | -5% | -$42.2K | |
| 2023-03-07 | 2023-03-03 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $14.34 | -760 | 232.8K | -0.3% | -$10.9K | |
| 2023-03-03 | 2023-03-01 | HCAT | Orenstein Daniel H. | GC | F - Tax | $14.29 | -2,186 | 133.1K | -2% | -$31.2K | |
| 2023-03-03 | 2023-03-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $14.29 | -1,734 | 82.3K | -2% | -$24.8K | |
| 2023-03-03 | 2023-03-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $14.29 | -3,351 | 233.6K | -1% | -$47.9K | |
| M | 2023-03-03 | 2023-03-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +3,083 | 180.9K | +2% | $0 |
| 2023-03-03 | 2023-03-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $14.29 | -1,569 | 177.8K | -0.9% | -$22.4K | |
| 2023-03-03 | 2023-03-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $14.29 | -7,717 | 870.4K | -0.9% | -$110.3K | |
| 2023-03-03 | 2023-03-01 | HCAT | Horstmeier Paul | COO | F - Tax | $14.29 | -4,464 | 154.9K | -3% | -$63.8K | |
| 2023-03-03 | 2023-03-01 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +1,142 | 58.3K | +2% | $0 | |
| 2023-03-03 | 2023-03-01 | HCAT | Alger Jason | CAO | F - Tax | $14.29 | -1,614 | 57.1K | -3% | -$23.1K | |
| 2023-02-24 | 2023-02-22 | HCAT | Hunt Bryan Truman | CFO | A - Grant | $0.00 | +100.0K | 236.9K | +73% | $0 | |
| 2023-02-24 | 2023-02-22 | HCAT | Orenstein Daniel H. | GC | A - Grant | $0.00 | +40.0K | 135.3K | +42% | $0 | |
| 2023-02-24 | 2023-02-22 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +35.0K | 84.0K | +71% | $0 | |
| 2023-02-24 | 2023-02-22 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +25.0K | 58.8K | +74% | $0 | |
| 2023-02-17 | 2023-02-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $13.82 | -662 | 49.0K | -1% | -$9,149 | |
| M | 2023-01-19 | 2023-01-17+ | HCAT | Hunt Bryan Truman | CFO | S - Sale | $12.28 | -4,409 | 139.3K | -3% | -$54.2K |
| 2023-01-19 | 2023-01-17 | HCAT | Llewelyn Linda | CHRO | S - Sale | $12.12 | -642 | 49.7K | -1% | -$7,781 | |
| 2022-12-19 | 2022-12-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $11.00 | -642 | 50.3K | -1% | -$7,062 | |
| 2022-12-08 | 2022-12-06 | HCAT | Alger Jason | CAO | S - Sale | $10.39 | -259 | 33.8K | -0.8% | -$2,691 | |
| 2022-12-05 | 2022-12-01 | HCAT | Freeman Kevin Lee | Chief Growth Off | F - Tax | $10.65 | -2,446 | 179.4K | -1% | -$26.0K | |
| 2022-12-05 | 2022-12-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $10.65 | -22.1K | 878.1K | -2% | -$234.9K | |
| 2022-12-05 | 2022-12-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $10.65 | -9,129 | 141.3K | -6% | -$97.2K | |
| 2022-12-05 | 2022-12-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $10.65 | -3,557 | 51.0K | -7% | -$37.9K | |
| 2022-12-05 | 2022-12-01 | HCAT | Orenstein Daniel H. | GC | F - Tax | $10.65 | -4,325 | 95.3K | -4% | -$46.1K | |
| 2022-12-05 | 2022-12-01 | HCAT | Horstmeier Paul | COO | F - Tax | $10.65 | -15.6K | 159.3K | -9% | -$165.7K | |
| 2022-12-05 | 2022-12-01 | HCAT | Alger Jason | CAO | F - Tax | $10.65 | -2,501 | 34.0K | -7% | -$26.6K | |
| 2022-11-17 | 2022-11-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $10.82 | -669 | 54.5K | -1% | -$7,239 | |
| 2022-11-14 | 2022-11-11 | HCAT | Burton Daniel D. | CEO, Dir | P - Purchase | $10.14 | +197.1K | 900.1K | +28% | +$2.00M | |
| 2022-10-20 | 2022-10-18 | HCAT | Llewelyn Linda | CHRO | S - Sale | $9.53 | -648 | 55.2K | -1% | -$6,175 | |
| 2022-09-19 | 2022-09-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $10.99 | -648 | 55.9K | -1% | -$7,122 | |
| 2022-09-12 | 2022-09-08 | HCAT | Freeman Kevin Lee | Chief Growth Off | A - Grant | $0.00 | +120.0K | 181.9K | +194% | $0 | |
| 2022-09-08 | 2022-09-06 | HCAT | Orenstein Daniel H. | GC | S - Sale | $11.27 | -2,838 | 99.6K | -3% | -$32.0K | |
| 2022-09-08 | 2022-09-08 | HCAT | Burton Daniel D. | CEO, Dir | P - Purchase | $10.99 | +90.8K | 703.1K | +15% | +$997.3K | |
| 2022-09-08 | 2022-09-06 | HCAT | Alger Jason | CAO | S - Sale | $11.28 | -262 | 36.5K | -0.7% | -$2,955 | |
| 2022-09-06 | 2022-09-01 | HCAT | Hinton Bryan Richard | CTO | F - Tax | $11.61 | -1,413 | 26.4K | -5% | -$16.4K | |
| 2022-09-06 | 2022-09-01 | HCAT | Alger Jason | CAO | F - Tax | $11.61 | -567 | 36.8K | -2% | -$6,583 | |
| 2022-09-06 | 2022-09-01 | HCAT | Nelli James Patrick Jr. | Pres | F - Tax | $11.61 | -3,359 | 265.0K | -1% | -$39.0K | |
| 2022-09-06 | 2022-09-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $11.61 | -1,414 | 150.5K | -0.9% | -$16.4K | |
| 2022-09-06 | 2022-09-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $11.61 | -7,362 | 612.3K | -1% | -$85.5K | |
| 2022-09-06 | 2022-09-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $11.61 | -848 | 56.5K | -1% | -$9,845 | |
| 2022-09-06 | 2022-09-01 | HCAT | Orenstein Daniel H. | GC | F - Tax | $11.61 | -1,225 | 102.4K | -1% | -$14.2K | |
| 2022-09-06 | 2022-09-01 | HCAT | Horstmeier Paul | COO | F - Tax | $11.61 | -2,869 | 174.9K | -2% | -$33.3K | |
| M | 2022-08-19 | 2022-08-18+ | HCAT | Gallagher Duncan | Dir | P - Purchase | $11.66 | +15.0K | 35.4K | +74% | +$175.0K |
| 2022-08-16 | 2022-08-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $13.14 | -668 | 57.4K | -1% | -$8,778 | |
| 2022-08-09 | 2022-08-09 | HCAT | Burton Daniel D. | CEO, Dir | P - Purchase | $11.62 | +176.5K | 619.7K | +40% | +$2.05M | |
| 2022-07-20 | 2022-07-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $16.06 | -648 | 58.0K | -1% | -$10.4K | |
| 2022-06-16 | 2022-06-14 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +11.7K | 26.8K | +77% | $0 | |
| 2022-06-16 | 2022-06-14 | HCAT | Smith S. Dawn | Dir | A - Grant | $0.00 | +11.7K | 26.8K | +77% | $0 | |
| 2022-06-16 | 2022-06-14 | HCAT | TEMPLETON MARK B | Dir | A - Grant | $0.00 | +11.7K | 21.5K | +119% | $0 | |
| 2022-06-16 | 2022-06-14 | HCAT | KANE JOHN A | Dir | A - Grant | $0.00 | +11.7K | 91.1K | +15% | $0 | |
| 2022-06-16 | 2022-06-14 | HCAT | Pramoda Anita | Dir | A - Grant | $0.00 | +11.7K | 15.0K | +355% | $0 | |
| 2022-06-16 | 2022-06-14 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +11.7K | 20.4K | +134% | $0 | |
| 2022-06-16 | 2022-06-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $12.20 | -648 | 58.7K | -1% | -$7,906 | |
| 2022-06-08 | 2022-06-06 | HCAT | Orenstein Daniel H. | GC | S - Sale | $14.85 | -2,838 | 103.7K | -3% | -$42.1K | |
| 2022-06-08 | 2022-06-06 | HCAT | Alger Jason | CAO | S - Sale | $14.95 | -261 | 37.4K | -0.7% | -$3,902 | |
| M | 2022-06-03 | 2022-06-01 | HCAT | Hinton Bryan Richard | CTO | F - Tax | $14.26 | -1,413 | 27.8K | -5% | -$20.2K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Horstmeier Paul | COO | F - Tax | $14.26 | -2,542 | 177.8K | -1% | -$36.3K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $14.26 | -4,687 | 151.9K | -3% | -$66.9K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Alger Jason | CAO | F - Tax | $14.27 | -567 | 37.6K | -1% | -$8,088 |
| M | 2022-06-03 | 2022-06-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $14.26 | -7,362 | 443.4K | -2% | -$105.0K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Nelli James Patrick Jr. | Pres | F - Tax | $14.26 | -3,359 | 268.4K | -1% | -$47.9K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $14.27 | -848 | 59.3K | -1% | -$12.1K |
| M | 2022-06-03 | 2022-06-01 | HCAT | Orenstein Daniel H. | GC | F - Tax | $14.26 | -1,224 | 106.5K | -1% | -$17.5K |
| DM | 2022-05-24 | 2022-05-18 | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $10.80 | +90.0K | 450.5K | +25% | +$971.9K |
| 2022-05-18 | 2022-05-16 | HCAT | Llewelyn Linda | CHRO | S - Sale | $15.87 | -1,860 | 60.2K | -3% | -$29.5K | |
| D | 2022-04-29 | 2022-04-27 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +5,000 | 107.7K | +5% | +$51.7K |
| M | 2022-04-21 | 2022-04-18 | HCAT | Llewelyn Linda | CHRO | S - Sale | $22.59 | -2,039 | 62.2K | -3% | -$46.1K |
| DM | 2022-04-14 | 2022-04-12 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.34 | +5,208 | 185.5K | +3% | +$79.9K |
| D | 2022-04-14 | 2022-04-12 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $25.16 | -5,208 | 180.3K | -3% | -$131.0K |
| DMA | 2022-04-08 | 2022-03-09 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +4,687 | 201.0K | +2% | +$74.2K |
| DMA | 2022-04-08 | 2022-03-09 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $25.33 | -20.7K | 180.3K | -10% | -$524.9K |
| 2022-03-17 | 2022-03-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $21.08 | -2,039 | 64.1K | -3% | -$43.0K | |
| DM | 2022-03-11 | 2022-03-09 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +4,687 | 201.0K | +2% | +$74.2K |
| DM | 2022-03-11 | 2022-03-09 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $25.31 | -23.2K | 177.8K | -12% | -$587.3K |
| 2022-03-09 | 2022-03-07 | HCAT | Alger Jason | CAO | S - Sale | $25.14 | -461 | 38.2K | -1% | -$11.6K | |
| 2022-03-07 | 2022-03-03 | HCAT | Llewelyn Linda | CHRO | S - Sale | $26.89 | -218 | 66.1K | -0.3% | -$5,862 | |
| 2022-03-07 | 2022-03-03 | HCAT | Orenstein Daniel H. | GC | S - Sale | $26.82 | -4,112 | 102.7K | -4% | -$110.3K | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Hinton Bryan Richard | CTO | F - Tax | $26.64 | -2,007 | 29.2K | -6% | -$53.5K |
| 2022-03-03 | 2022-03-01 | HCAT | Hinton Bryan Richard | CTO | A - Grant | $0.00 | +1,861 | 29.5K | +7% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Hunt Bryan Truman | CFO | F - Tax | $26.64 | -2,158 | 154.5K | -1% | -$57.5K |
| 2022-03-03 | 2022-03-01 | HCAT | Hunt Bryan Truman | CFO | A - Grant | $0.00 | +2,420 | 156.9K | +2% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $26.64 | -13.3K | 350.5K | -4% | -$354.3K |
| M | 2022-03-03 | 2022-03-01 | HCAT | Burton Daniel D. | CEO, Dir | A - Grant | $0.00 | +11.9K | 354.0K | +3% | $0 |
| 2022-03-03 | 2022-03-01 | HCAT | Orenstein Daniel H. | GC | A - Grant | $0.00 | +1,861 | 107.1K | +2% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Orenstein Daniel H. | GC | F - Tax | $26.64 | -1,812 | 106.8K | -2% | -$48.3K |
Purchase Sale Sale after option exercise All abbreviations